BSECompany UpdateMgmt Change30 Sept 2026
SaiParenteralsLtd
SaiParenteralsLtd has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
SaiParenteralsLtd has informed BSE about the appointment of Chief Operating Officer.
BSECompany UpdateMgmt Change30 Sept 2026
SaiParenteralsLtd
SaiParenteralsLtd has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
SaiParenteralsLtd has informed BSE about the appointment of a new Company Secretary.
BSECompany UpdateMgmt Change30 Sept 2026
SaiParenteralsLtd
SaiParenteralsLtd has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
SaiParenteralsLtd has informed BSE about the cessation of its Company Secretary.
BSECompany UpdateMgmt Change30 Sept 2026
SaiParenteralsLtd
SaiParenteralsLtd has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
SaiParenteralsLtd has informed BSE about the appointment of Chief Operating Officer.
BSECompany UpdateMgmt Change30 Sept 2026
SaiParenteralsLtd
SaiParenteralsLtd has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
SaiParenteralsLtd has informed BSE about the appointment of a new Company Secretary.
BSECompany UpdateMgmt Change30 Sept 2026
SaiParenteralsLtd
SaiParenteralsLtd has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
SaiParenteralsLtd has informed BSE about the cessation of its Company Secretary.
BSECompany UpdateMgmt Change30 Sept 2026
SaiParenteralsLtd
SaiParenteralsLtd has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
SaiParenteralsLtd has informed BSE about the appointment of Chief Operating Officer.
BSECompany UpdateMgmt Change30 Sept 2026
SaiParenteralsLtd
SaiParenteralsLtd has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
SaiParenteralsLtd has informed BSE about the appointment of a new Company Secretary.
BSECompany Update▲ PositiveOrder Win25 Aug 2026
Sai Parenterals Ltd
Announcement under Regulation 30 (LODR)
Sai Parenterals Ltd, an integrated CDMO and branded generics enterprise, has announced that its Australian subsidiary, Noumed Pharmaceuticals Pty Ltd, has renewed its OTC Medicines Supply Agreement with one of Australia's leading pharmacy chains. The renewal carries an expanded product portfolio, a long agreement tenure, and a higher agreement value, and is projected at AUD 30 million over a three-year term.
BSECompany Update▲ PositiveOrder Win25 Aug 2026
Sai Parenterals Ltd
Announcement under Regulation 30 (LODR)
Sai Parenterals Ltd's subsidiary Noumed Pharmaceuticals has renewed a long-term OTC medicines supply agreement with a leading Australian pharmacy chain, with a 3-year term and a projected value of AUD 30 million (approximately Rs. 204 crores).
BSECompany Update25 Aug 2026
Sai Parenterals Ltd
Intimation of schedule of Analyst/Institutional Investors Meeting scheduled to be held on 31st August, 2026
Sai Parenterals Ltd has announced an analyst/institutional investor meeting on August 31, 2026, to be held in Mumbai. The meeting will be in person and hosted by Strategic Growth Advisors Pvt. Ltd. No unpublished price-sensitive information will be shared.
BSECompany Update20 Aug 2026
Sai Parenterals Ltd
Newspaper Publication of Notice of 25th Annual General Meeting of the Comapny for FY2025-26.
Sai Parenterals Ltd has published a notice of its 25th Annual General Meeting (AGM) for the financial year 2025-26, to be held on September 10, 2026, through video conferencing.
BSECompany UpdateResults20 Aug 2026
Sai Parenterals Ltd
Submission of Newspaper Publication in Form PAS-1 for change or variation in the objects of utilisation of IPO Proceeds.
Sai Parenterals Ltd announced submission of newspaper publication in PAS-1 for change and variation in the objects of utilization of IPO proceeds.
BSEAGM/EGM19 Aug 2026
Sai Parenterals Ltd
Book closure intimation for 25th Annual General Meeting
Sai Parenterals Ltd has announced the book closure and cut-off date for its 25th Annual General Meeting, scheduled to be held on September 10, 2026, through video conference. The register of members and share transfer books will be closed from September 4 to 10, 2026.
BSEOthersResults19 Aug 2026
Sai Parenterals Ltd
Annual Report of the company for FY 2025-26
Sai Parenterals Ltd submitted its 25th Annual Report for FY 2025-26 under Regulation 34 of SEBI (LODR) Regulations, 2015. The report is dispatched to shareholders on 19th August, 2026, and the Annual General Meeting is scheduled for 10th September, 2026.
BSEAGM/EGM19 Aug 2026
Sai Parenterals Ltd
Notice of 25th Annual General Meeting for the Financial Year 2025-26 scheduled to be held on 10th September, 2026.
Sai Parenterals Ltd has announced the notice of its 25th Annual General Meeting for the financial year 2025-26, scheduled to be held on September 10, 2026, through video conference.
BSECompany UpdateResults18 Aug 2026
Sai Parenterals Ltd
Transcript of Earnings Call held on 12th August, 2026 at 02:30 PM (IST) for Quarter 1 of FY 2026-27.
Sai Parenterals Ltd has announced its Q1 FY 2027 earnings, with consolidated revenue of Rs. 182 crores, gross profit of Rs. 76 crores, EBITDA of Rs. 27 crores, and profit after tax of Rs. 8 crores. The company has also announced a proposed variation in the objects of the IPO issue, redeploying Rs. 101.85 crores towards majority stakes in two operating pharmaceutical assets.
BSECompany UpdateResults12 Aug 2026
Sai Parenterals Ltd
Audio Recording of the Earnings call held on 12th August, 2026
Sai Parenterals Ltd has made the audio recording of its Q1 2026 earnings call available on its website.
BSECompany Update▲ PositiveResults12 Aug 2026
Sai Parenterals Ltd
Investor Presentation Q1 FY 2027
Sai Parenterals Ltd has disclosed its investor presentation for Q1 FY 2027, highlighting its global IP-led pharmaceutical platform, integrated CDMO and branded generics enterprise, and long-term contracted international revenue. The company has a strong R&D-driven CDMO engine, with a 7.5-year exclusive OTC supply agreement in Australia and a 4-year exclusive anti-tuberculosis contract in the Philippines.
BSECompany Update▲ PositiveResults11 Aug 2026
Sai Parenterals Ltd
Press Release
Sai Parenterals Limited has announced its un-audited Financial Results for the quarter ended 30th June 2026, with total revenue of Rs. 182.4 crore, gross profit of Rs. 76.2 crore, EBITDA of Rs. 27.3 crore, and PAT of Rs. 7.9 crore.